Participate in Clinical Trials
Treatment Units for Research on Neurocognition and Schizophrenia (TURNS)

What is this study about?

Antipsychotic medications may lead to some improvement in cognition in schizophrenia. However, patients with schizophrenia often perform two or three standard deviations below the mean of controls on neurocognitive tests and newer antipsychotic drugs only make up a fraction of that difference. This gap in the effectiveness of antipsychotic drugs for neurocognition has inspired a search for co-treatments that can be added to an antipsychotic to improve cognition.

The TURNS program is a National Institute of Mental Health (NIMH) supported network that will provide an infrastructure for clinical studies of pharmacological agents for enhancing neurocognition in patients with schizophrenia.

Contact information for questions or enrollment

• Shelly Crosby, Project Recruiter (310) 478-3711 ext. 49234
• Stephen Marder, M.D., Principal Investigator (310) 268-3647

Disclaimer:
This web site, is offered as a public service and is not intended to substitute for professional medical care.

Questions/comments about content?
Email: info@mirecc.org

Technical questions or error reporting?
Email: support@mirecc.org.

MIRECC Site Map | Contact Us | Mental Health Strategic Health Care Group | Disclaimer

This site is maintained by the Mental Illness Research, Education and Clinical Center (MIRECC) of the VA Desert Pacific Healthcare Network

Copyright © 1999-2007 - MIRECC, VA Desert Pacific Healthcare System